Pembrolizumab + CVA21 in Advanced NSCLC
Clinical trial NCT02824965 · UNKNOWN
Trial details
- NCT number
- NCT02824965
- Sponsor
- Olivia Newton-John Cancer Research Institute
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-09
- Primary completion
- 2021-07-01
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.